bluebird bio Receives $30,000,000 Series C Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c8f56fb-3102-4b46-a848-33e54811ea66&Preview=1 -
Date
4/20/2011 -
Company Name
bluebird bio -
Mailing Address
840 Memorial Drive Cambridge, MA 02139 -
Company Description
bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options. -
Website
http://www.bluebirdbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Series C -
Proceeds Purposes
The funds will be used to focus on driving forward the company’s clinical trials while strategically investing in its pipeline and core product platform capabilities. -
M&A Terms
-
Venture Investor
ARCH Venture Partners -
Venture Investor
Third Rock Ventures -
Venture Investor
TVM Capital -
Venture Investor
Forbion Capital Partners -
Venture Investor
Easton Capital
